hc1 Insights™, a pioneer in transforming laboratory data into actionable insights, is thrilled to announce the successful raise of $6.5 million in funding. Founded in 2011, hc1 has been at the forefront of harnessing the immense potential of complex laboratory data, empowering labs to enhance operational efficiency and offer personalized patient care. With a decade of innovation behind it, hc1 has become the trusted leader in delivering real-time risk signals through its cutting-edge Lab Insights Platform™, which consolidates diagnostic information for over 200 million patients and manages more than 30 billion clinical transactions each month, built on the robust infrastructure of Amazon Web Services (AWS). The funding will strategically enable hc1 to expand its suite of solutions, including hc1 Performance Analytics™, hc1 Operations Management™, hc1 PrecisionDx Advisor™, and hc1 Workforce Optimization™, ensuring a continued focus on improving patient outcomes by optimizing testing and treatment pathways. As security remains paramount, hc1 adheres to the stringent HITRUST CSF® v9.3 certification standards, ensuring data integrity and compliance. With this new capital, hc1 is not only investing in its technology and talent but is further committing to its mission: "Right Patient. Right Test. Right Prescription." The company is excited about the future and is poised to unlock even more sophisticated insights that will revolutionize both lab operations and patient care, ultimately advancing the healthcare landscape for millions.








